Diabetes mellitus is a condition in which the pancreas no longer produces enough insulin or when cells stop responding to the insulin that is produced, so that glucose in the blood cannot be absorbed into the cells of the body. Symptoms include frequent urination, lethargy, excessive thirst, and hunger. The treatment includes changes in diet, oral medications, and in some cases, daily injections of insulin.
FDA approves pediatric use of Dexcom’s G4 Platinum continuous glucose monitoring system – The U.S. Food and Drug Administration today approved the expanded use of the Dexcom G4 Platinum Continuous Monitoring System for patients with diabetes ages 2 to 17 years. The G4 Platinum System, which monitors blood glucose levels in people with diabetes, had been approved for patients ages 18 and older.
Ingredients in chocolate, tea and berries could guard against diabetes – Eating high levels of flavonoids including anthocyanins and other compounds (found in berries, tea, and chocolate) could offer protection from type 2 diabetes. Findings reveal that high intakes of these dietary compounds are associated with lower insulin resistance and better blood glucose regulation.
Fish derived serum omega-3 fatty acids help reduce the risk of type 2 diabetes – High concentrations of serum long-chain omega-3 fatty acids from fish and fish oils may help reduce the risk of type 2 diabetes. Type 2 diabetes is becoming increasingly widespread throughout the world, including Finland.
Duration of diabetes and advancing age independently predict diabetes complications, risk of death – The duration of diabetes and advancing age independently predict diabetes severity and risk of death in older adults with type 2 diabetes. In a new study led by Kaiser Permanente and the University of Chicago, researchers investigated contemporary rates of diabetes complications and risk of death then contrasted them across categories of age and duration of diabetes.
McMaster scientists unlock secrets of diabetes drug — How and why metformin needs to interact with insulin to be effective – About 120 million people around the world with Type 2 diabetes – and two million in Canada – take the drug metformin to control their disease. While doctors know metformin needs to interact with insulin to be effective, and that it can’t lower blood sugar on its own, no one has been able to explain how and why this happens.
Antipsychotic drug use in children for mood/behavior disorders increases type 2 diabetes risk – Ceratin antipsychotic medications prescribed to children and young adults with behavioral problems or mood disorders may put them at unnecessary risk for type 2 diabetes, a Vanderbilt University Medical Center study shows.
Red meat linked to greater diabetes risk — Increasing amount of red meat in your diet ‘can raise risk of developing Type 2 Diabetes – Eating more red meat over time is associated with an increased risk of type-2 diabetes mellitus (T2DM) in a follow-up of three studies of about 149,000 U.S. men and women. “Our results confirm the robustness of the association between red meat and T2DM and add further evidence that limiting red meat consumption over time confers benefits for T2DM prevention,” says author.
US FDA approves three new drug treatments for type 2 diabetes – Nesina, Kazano, and Oseni – The U.S. Food and Drug Administration approved three new related products for use with diet and exercise to improve blood sugar control in adults with type 2 diabetes: Nesina (alogliptin) tablets, Kazano (alogliptin and metformin hydrochloride) tablets, and Oseni (alogliptin and pioglitazone) tablets.
Kidney disease accounts for most of the increased risk of dying early among diabetics — Preventing and treating kidney disease in those with diabetes could save lives – One in every 10 Americans has diabetes, and a third or more of those with the condition will develop kidney disease. That means almost 3 percent of Americans suffer from chronic kidney disease.
Study compares rate of death following diabetes diagnosis among normal weight and overweight adults — Thinner diabetics face higher death rate — New-onset diabetics with normal BMI have higher mortality rate than heavier diabetics – American adults of a normal weight with new-onset diabetes die at a higher rate than overweight/obese adults with the same disease. A Northwestern Medicine study found that normal-weight participants experienced both significantly higher total and non-cardiovascular mortality than overweight/obese participants.
